43 related articles for article (PubMed ID: 20337729)
1. Concentration and Methylation of Cell-Free DNA from Blood Plasma as Diagnostic Markers of Renal Cancer.
Skrypkina I; Tsyba L; Onyshchenko K; Morderer D; Kashparova O; Nikolaienko O; Panasenko G; Vozianov S; Romanenko A; Rynditch A
Dis Markers; 2016; 2016():3693096. PubMed ID: 27725787
[TBL] [Abstract][Full Text] [Related]
2. Circulating Tumor DNA for Modern Cancer Management.
Heitzer E
Clin Chem; 2019 Oct; ():. PubMed ID: 31672857
[No Abstract] [Full Text] [Related]
3. Cell-free DNA as a Promising Diagnostic Biomarker in Prostate Cancer: A Systematic Review and Meta-Analysis.
Zhang C; Chao F; Wang S; Han D; Chen G
J Oncol; 2022; 2022():1505087. PubMed ID: 35669243
[TBL] [Abstract][Full Text] [Related]
4. Advances in Prognostic Methylation Biomarkers for Prostate Cancer.
Lam D; Clark S; Stirzaker C; Pidsley R
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33076494
[TBL] [Abstract][Full Text] [Related]
5. Research landscape of liquid biopsies in prostate cancer.
Campos-Fernández E; Barcelos LS; de Souza AG; Goulart LR; Alonso-Goulart V
Am J Cancer Res; 2019; 9(7):1309-1328. PubMed ID: 31392072
[TBL] [Abstract][Full Text] [Related]
6. Quantitative and Qualitative Analysis of Circulating Cell-Free DNA Can Be Used as an Adjuvant Tool for Prostate Cancer Screening: A Meta-Analysis.
Yin C; Luo C; Hu W; Ding X; Yuan C; Wang F
Dis Markers; 2016; 2016():3825819. PubMed ID: 27766004
[TBL] [Abstract][Full Text] [Related]
7. Capture of esophageal and breast cancer cells with polymeric microfluidic devices for CTC isolation.
Ohnaga T; Shimada Y; Takata K; Obata T; Okumura T; Nagata T; Kishi H; Muraguchi A; Tsukada K
Mol Clin Oncol; 2016 Apr; 4(4):599-602. PubMed ID: 27073672
[TBL] [Abstract][Full Text] [Related]
8. When Prostate Cancer Circulates in the Bloodstream.
Vlaeminck-Guillem V
Diagnostics (Basel); 2015 Oct; 5(4):428-74. PubMed ID: 26854164
[TBL] [Abstract][Full Text] [Related]
9. Methylated circulating tumor DNA in blood: power in cancer prognosis and response.
Warton K; Mahon KL; Samimi G
Endocr Relat Cancer; 2016 Mar; 23(3):R157-71. PubMed ID: 26764421
[TBL] [Abstract][Full Text] [Related]
10. Interindividual epigenetic variation in ABCB1 promoter and its relationship with ABCB1 expression and function in healthy Chinese subjects.
Wu LX; Wen CJ; Li Y; Zhang X; Shao YY; Yang Z; Zhou HH
Br J Clin Pharmacol; 2015 Nov; 80(5):1109-21. PubMed ID: 25940551
[TBL] [Abstract][Full Text] [Related]
11. Prognostic DNA methylation markers for prostate cancer.
Strand SH; Orntoft TF; Sorensen KD
Int J Mol Sci; 2014 Sep; 15(9):16544-76. PubMed ID: 25238417
[TBL] [Abstract][Full Text] [Related]
12. Methylated Glutathione S-transferase 1 (mGSTP1) is a potential plasma free DNA epigenetic marker of prognosis and response to chemotherapy in castrate-resistant prostate cancer.
Mahon KL; Qu W; Devaney J; Paul C; Castillo L; Wykes RJ; Chatfield MD; Boyer MJ; Stockler MR; Marx G; Gurney H; Mallesara G; Molloy PL; Horvath LG; Clark SJ;
Br J Cancer; 2014 Oct; 111(9):1802-9. PubMed ID: 25144624
[TBL] [Abstract][Full Text] [Related]
13. Comment on Ma XL et al.: prognostic role of circulating tumor cells and disseminated tumor cells in patients with prostate cancer: a systematic review and meta-analysis.
Xia Q; Liu C; He S; Wang B
Tumour Biol; 2014 Aug; 35(8):7403-4. PubMed ID: 24923911
[No Abstract] [Full Text] [Related]
14. Prognostic role of circulating tumor cells and disseminated tumor cells in patients with prostate cancer: a systematic review and meta-analysis.
Ma X; Xiao Z; Li X; Wang F; Zhang J; Zhou R; Wang J; Liu L
Tumour Biol; 2014 Jun; 35(6):5551-60. PubMed ID: 24563278
[TBL] [Abstract][Full Text] [Related]
15. APC gene hypermethylation and prostate cancer: a systematic review and meta-analysis.
Chen Y; Li J; Yu X; Li S; Zhang X; Mo Z; Hu Y
Eur J Hum Genet; 2013 Sep; 21(9):929-35. PubMed ID: 23299921
[TBL] [Abstract][Full Text] [Related]
16. DNA methylation in promoter region as biomarkers in prostate cancer.
Yang M; Park JY
Methods Mol Biol; 2012; 863():67-109. PubMed ID: 22359288
[TBL] [Abstract][Full Text] [Related]
17. Association of circulating tumor cells with tumor-related methylated DNA in patients with hormone-refractory prostate cancer.
Okegawa T; Nutahara K; Higashihara E
Int J Urol; 2010 May; 17(5):466-75. PubMed ID: 20337729
[TBL] [Abstract][Full Text] [Related]
18. Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer.
Okegawa T; Nutahara K; Higashihara E
J Urol; 2008 Oct; 180(4):1342-7. PubMed ID: 18707699
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of circulating tumor cells in patients with hormone refractory prostate cancer.
Okegawa T; Nutahara K; Higashihara E
J Urol; 2009 Mar; 181(3):1091-7. PubMed ID: 19150091
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
